# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
ANKTIVA® Drug Substance completed and released with two-year storage stability data sufficient for 170,000 doses of ANKTIVA pro...
Unlocking global access to Bacillus Calmette-Guerin (BCG) for cancer therapy. ImmunityBio partners with Serum Institute to expa...
AAPLNVDATSLACOINBAPLTRDJTAIIBRXCVNAData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio's recently ap...